March 2016 (Medical News Today)
New Australian recommendations for the management of hepatitis C virus (HCV) infection have been released in a consensus statement, with a summary published online by the Medical Journal of Australia.
Professor Alexander Thompson, director of gastroenterology at St Vincent’s Hospital in Melbourne and author of the MJA summary, wrote that the timing was right for the new recommendations in the wake of the listing of several direct-acting antiviral (DAA) therapies for HCV by the Pharmaceutical Benefits Scheme earlier this month.
“The introduction of DAA therapies for HCV that are highly effective and well tolerated is a major medical advance,” Professor Thompson wrote. “All Australians living with HCV should now be considered for antiviral therapy.”